Skip to main content
. 2006 Mar;50(3):968–974. doi: 10.1128/AAC.50.3.968-974.2006

TABLE 1.

Characteristics of patients in the artesunate suppository and i.m. artemether groups at the time of admission to the studya

Measure Value for group
Artesunate suppositories i.m. artemether
No. of patients 41 38
Age (yr) 3.6 ± 1.6 3.8 ± 2.2
Sex (% males) 20 (50) 21 (55)
Initial drug dose (mg/kg) 11.2 ± 2.2 3.6 ± 0.9
Body wt (kg) 12.6 ± 3.4 13.4 ± 4.8
Axillary temp (°C) 38.7 ± 1.1 38.7 ± 1.5
Respiratory rate (/min) 43 43
Pulse rate (/min) 122 ± 18 122 ± 16
Blantyre coma score 4.5 ± 1.0 4.7 ± 0.7
Parasite density (/μl) 69,000 (770-458,000)b 40,100 (775-473,000)
Mixed infection with P. vivax (%) 1 (2) 3 (8)
Hemoglobin (g/dl) 9.1 ± 2.2 8.4 ± 3.0
Blood glucose (mmol/liter) 7.1 ± 2.7 6.6 ± 2.4
Plasma bicarbonate (mmol/liter) 18.5 ± 5.3 17.1 ± 4.8
Plasma lactate (mmol/liter) 4.4 ± 2.7 5.5 ± 4.3
Plasma urea (mmol/liter) 4.1 ± 1.7 3.4 ± 1.2
Plasma bilirubin (μmol/liter) 28 ± 22 28 ± 25
a

Data are expressed as means ± standard deviations or medians (ranges) unless otherwise specified.

b

Mann-Whitney U test, P < 0.05.